The efficiency of the RNA-guided AsCas12a nuclease of Acidaminococcus sp. was compared with SpCas9 from Streptococcus pyogenes, for functional genomics in Schistosoma mansoni. We deployed optimized conditions for the ratio of guide RNAs to the nuclease, donor templates, and electroporation parameters, to target a key schistosome enzyme termed omega-1. Programmed cleavages catalyzed by Cas12a and Cas9 resulted in staggered- and blunt-ended strand breaks, respectively. AsCas12a was more efficient than SpCas9 for gene knockout, as determined by TIDE analysis. CRISPResso2 analysis confirmed that most mutations were deletions. Knockout efficiency of both nucleases markedly increased in the presence of single-stranded oligodeoxynucleotide (ssODN) template. With AsCas12a, ssODNs representative of both the non-CRISPR target (NT) and target (T) strands were tested, resulting in KO efficiencies of 15.67, 28.71, and 21.43% in the SpCas9 plus ssODN, AsCas12a plus NT-ssODN, and AsCas12a plus T-ssODN groups, respectively. Trans-cleavage against the ssODNs by activated AsCas12a was not apparent in vitro. SpCas9 catalyzed more precise transgene insertion, with knock-in efficiencies of 17.07% for the KI_Cas9 group, 14.58% for KI_Cas12a-NT-ssODN, and 12.37% for KI_Cas12a-T-ssODN. Although AsCas12a induced fewer mutations per genome than SpCas9, the phenotypic impact on transcription and expression of omega-1 was similar for both nucleases.
Streptococcus suis is a major pathogen in pigs, causing diseases like meningitis, septicemia, and pneumonia, and has become a serious zoonosis in humans, particularly in countries with intensive swine production. Human infections have risen significantly, especially in Thailand, where serotype 2 is most commonly associated with disease in both pigs and humans. Traditional methods of identifying S. suis and its serotypes, such as bacterial culture, biochemical testing, and agglutination tests, face challenges due to variability and limited antisera availability, leading to the need for alternative approaches. In this study, we developed a novel RPA-NALFIA assay targeting the recN and cps2J genes of S. suis serotype 2. This method demonstrated accurate identification without cross-reactivity among 28 other bacterial species, with a detection limit of 103 CFU/mL, comparable to PCR methods. Food safety concerns are heightened by the discovery of S. suis contamination in pork, a major infection route when consumed undercooked. Our surveillance in central Thailand revealed that 49.3% of pork samples were contaminated with S. suis, with serotype 2 detected in 2.6% of samples. The RPA-NALFIA method proved effective, showing 100% sensitivity and 97.5% specificity. This assay offers rapid, reliable detection suitable for point-of-care testing in resource-limited settings.